Empowering discovery. Advancing therapy. For more than 30 years, Miltenyi Biotec has played an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy. Our mission is to advance scientific understanding and medicine by providing solutions for cell and gene therapy and biomedical research. We believe in biomedical science as the strongest driver to change the way we treat cancer, autoimmune diseases, and neurodegenerative disorders. The design of therapeutics is evolving away from chemistry-based science towards individual treatments that focus on cell-based approaches and more targeted drugs. We are driving the revolution that is reinventing medicine and advancing it to a level that will make cancer and other serious diseases history. Miltenyi Biotec was founded in 1989 based on the invention of MACS® Technology. Our technological solutions have made an important contribution to the advancement of biomedical science ever since. Today our more than 18,000 products play a vital role in paving the way for the medicine of tomorrow. We offer comprehensive solutions for our customers’ workflows, from basic research to translation into clinical applications. Our integrated technologies span a broad range of applications, from cellular research to genetic sequencing, high-content imaging, and commercial-scale manufacturing of cellular therapies. We are scientists ourselves and share our customers’ mindset. We are passionate about unraveling nature’s complexity. This is what drives our research and inspires our products.